Connor, Clark & Lunn Investment Management (CC&L)’s Haemonetics HAE Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-174,287	Closed	-$13M	–	1585
2025 Q2	$13M	Sell	174,287 -50,085	-22%	-$3.32M	0.05%	336
2025 Q1	$14.3M	Sell	224,372 -27,770	-11%	-$1.89M	0.06%	249
2024 Q4	$19.7M	Buy	252,142 +31,689	+14%	+$2.55M	0.09%	174
2024 Q3	$17.7M	Buy	220,453 +179,621	+440%	+$14.5M	0.09%	184
2024 Q2	$3.38M	Buy	+40,832	New	+$3.59M	0.01%	522
2023 Q3	–	Sell	-17,963	Closed	-$1.53M	–	1426
2023 Q2	$1.53M	Buy	+17,963	New	+$1.52M	0.01%	675
2018 Q3	–	Sell	-3,800	Closed	-$341K	–	1012
2018 Q2	$341K	Buy	+3,800	New	+$321K	﹤0.01%	855
2017 Q4	–	Sell	-5,925	Closed	-$266K	–	808
2017 Q3	$266K	Buy	5,925 +700	+13%	+$29.1K	﹤0.01%	719
2017 Q2	$206K	Buy	+5,225	New	+$215K	﹤0.01%	741
2016 Q3	–	Sell	-10,000	Closed	-$290K	–	868
2016 Q2	$290K	Sell	10,000 -1,325	-12%	-$40K	﹤0.01%	679
2016 Q1	$396K	Sell	11,325 -2,900	-20%	-$93.7K	﹤0.01%	604
2015 Q4	$459K	Sell	14,225 -13,575	-49%	-$440K	﹤0.01%	558
2015 Q3	$898K	Buy	+27,800	New	+$1.05M	0.01%	422

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s HAE Position: Q3 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Haemonetics (HAE) in Q3 2025, closing a stake of 174,287 shares — an estimated $13M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in HAE in Q3 2015 and held it in 13 quarters. The position peaked at $19.7M in Q4 2024. 301 funds tracked by Wall St. Rank hold HAE as of Q3 2025.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Haemonetics position as of Q3 2025 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 174,287 Haemonetics shares in Q3 2025, an estimated $13M.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Haemonetics in Q3 2015 and held it in 13 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s Haemonetics position peaked at $19.7M in Q4 2024.
301 funds tracked by Wall St. Rank held Haemonetics as of Q3 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2025, filed 13 Nov 2025.